mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.002 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.003 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.003 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.004 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.004 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.004 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |